Nature's Sunshine Products, Inc. (NATR)
10.36
+0.08
(+0.78%)
USD |
NASDAQ |
Nov 13, 16:00
10.36
0.00 (0.00%)
After-Hours: 19:59
Nature's Sunshine Products Enterprise Value : 110.38M for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 110.38M |
| November 11, 2026 | 110.90M |
| November 10, 2026 | 121.68M |
| November 09, 2026 | 123.24M |
| November 06, 2026 | 120.64M |
| November 05, 2026 | 110.03M |
| November 04, 2026 | 154.89M |
| November 03, 2026 | 141.50M |
| November 02, 2026 | 140.63M |
| October 30, 2026 | 144.63M |
| October 29, 2026 | 145.15M |
| October 28, 2026 | 148.11M |
| October 27, 2026 | 147.06M |
| October 26, 2026 | 144.98M |
| October 23, 2026 | 142.89M |
| October 22, 2026 | 147.41M |
| October 21, 2026 | 144.80M |
| October 20, 2026 | 152.63M |
| October 19, 2026 | 149.85M |
| October 16, 2026 | 151.41M |
| October 15, 2026 | 151.41M |
| October 14, 2026 | 150.89M |
| October 13, 2026 | 153.50M |
| October 12, 2026 | 152.63M |
| October 09, 2026 | 151.41M |
| Date | Value |
|---|---|
| October 08, 2026 | 150.19M |
| October 07, 2026 | 150.54M |
| October 06, 2026 | 149.67M |
| October 05, 2026 | 147.24M |
| October 02, 2026 | 148.11M |
| October 01, 2026 | 150.54M |
| September 30, 2026 | 152.28M |
| September 29, 2026 | 163.68M |
| September 28, 2026 | 164.91M |
| September 25, 2026 | 166.50M |
| September 24, 2026 | 166.32M |
| September 23, 2026 | 167.03M |
| September 22, 2026 | 171.78M |
| September 21, 2026 | 168.26M |
| September 18, 2026 | 168.26M |
| September 17, 2026 | 169.49M |
| September 16, 2026 | 169.49M |
| September 15, 2026 | 169.14M |
| September 14, 2026 | 175.83M |
| September 11, 2026 | 177.59M |
| September 10, 2026 | 178.65M |
| September 09, 2026 | 179.53M |
| September 08, 2026 | 182.35M |
| September 04, 2026 | 185.87M |
| September 03, 2026 | 182.00M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Niagen Bioscience, Inc. | 101.30M |
| Cyanotech Corp. | 15.05M |
| Mannatech, Inc. | 17.69M |
| Natural Alternatives International, Inc. | 48.46M |
| USANA Health Sciences, Inc. | 99.45M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.89M |
| Revenue (Quarterly) | 116.60M |
| Total Expenses (Quarterly) | 114.71M |
| EPS Diluted (Quarterly) | 0.1058 |
| Gross Profit Margin (Quarterly) | 70.11% |
| Profit Margin (Quarterly) | 1.62% |
| Earnings Yield | 7.85% |
| Operating Earnings Yield | 13.73% |
| Normalized Earnings Yield | 7.850 |